project id: TCGA-HNSC; case submitter id: TCGA-P3-A6SW; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 7.1; age at index: 50; days to birth: -18536; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 18536; ajcc clinical m: M0; ajcc clinical n: N2b; ajcc clinical stage: Stage IVA; ajcc clinical t: T4; ajcc pathologic m: MX; ajcc pathologic n: N3; ajcc pathologic stage: Stage IVB; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1120.0; icd 10 code: C09.9; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Tonsil, NOS; synchronous malignancy: No; tissue or organ of origin: Tonsil, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 3039; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-P3-A6SW-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0;